Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 12 Breast Neoplasms 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 10 Neoplasms 8 Melanoma 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Lymphoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡